Aptinyx to Present at the 2019 Wedbush PacGrow Healthcare Conference
06 août 2019 08h33 HE
|
Aptinyx Inc.
EVANSTON, Ill., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous...
Fulgent Genetics Partners with Parkinson’s Foundation on Launch of Genetic Testing Initiative for People with Parkinson’s Disease
16 juil. 2019 09h15 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) and the Parkinson’s Foundation today announced a collaboration on a new genetic testing initiative for...
Aptinyx to Report First Quarter 2019 Financial Results on Tuesday, May 14, 2019
06 mai 2019 07h27 HE
|
Aptinyx Inc.
EVANSTON, Ill., May 06, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
Aptinyx Reports Positive Data from Phase 1 Study of Novel NMDA Receptor Modulator, NYX-458, in Healthy Volunteers
30 avr. 2019 07h27 HE
|
Aptinyx Inc.
Favorable overall safety, tolerability, and pharmacokinetic profile—no serious adverse events reported across wide dose range Achieved ample CNS exposure consistent with exposure observed at...
Sorrento Therapeutics Announces Discovery of a Potential Non-Dopaminergic Approach to Controlling Parkinson’s Motor Symptoms With Resiniferatoxin (RTX) Intrathecal Administration
10 avr. 2019 09h00 HE
|
Sorrento Therapeutics, Inc.
SAN DIEGO, April 10, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announces positive and better than initially hoped for top line results in a discovery study...
Servier backs an American startup at LabCentral in the field of mitochondrial health for neurodegenerative and rare diseases
14 nov. 2018 02h00 HE
|
LabCentral
PARIS, France and CAMBRIDGE, Mass. USA, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Servier, an independent international pharmaceutical laboratory, and LabCentral, a well-known launchpad for innovative life...
IGC Partners to Advance Cannabinoid Based Parkinson's Disease Therapy Research -- CFN Media
14 mars 2018 09h00 HE
|
CFN Media
Seattle, WA , March 14, 2018 (GLOBE NEWSWIRE) -- CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article...
MRI Interventions' ClearPoint® Neuro Navigation Technology Highlighted in Voyager Therapeutics, Inc. Interim Parkinson’s Disease Gene Therapy Study Results
23 juin 2016 16h05 HE
|
MRI Interventions, Inc.
IRVINE, Calif., June 23, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next...
MRI Interventions’ ClearPoint® Neuro Navigation System Utilized for the First Time at Inova Fairfax Hospital
31 mai 2016 16h30 HE
|
ClearPoint Neuro, Inc.
IRVINE, Calif., May 31, 2016 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative neuro navigation platforms for...
Senior Helpers Announces Expanded Coverage In Westchester County, New York
08 avr. 2016 07h22 HE
|
Senior Helpers
YONKERS, N.Y., April 8, 2016 (GLOBE NEWSWIRE) -- Senior Helpers®, one of the nation's largest in-home senior care companies, announced today that it is expanding its coverage in the New York City...